Skip to main content
OpenTrials
Completed

NCT Number: NCT05052411

Beta Testing of a Smartphone App for HIV Prevention in Malaysian MSM

This project will involve beta testing of the JomPrEP app to assess its usability and acceptability among Malaysian MSM.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

University of Malaya

Kuala Lumpur, Malaysia

About this study

Given the evolving HIV epidemic among MSM and their challenges with accessing prevention services, we previously proposed to adapt, expand, and refine an existing app (namely the HealthMindr app) to deliver an integrated HIV prevention intervention that will promote HIV testing and linkage to PrEP and that incorporates screening and support for P/SUD for Malaysian MSM. We now plan to conduct expanded beta testing of the newly designed JomPrEP app to assess its usability and acceptability among Malaysian MSM.

Following wireframing and usability testing, Keymind (an experienced mobile app development company that has significant experience in building HIPAA-compliant apps, including HealthMindr) will apply a user interface (UI) design (i.e., colors/branding) to the interactive prototype, followed by the final development of the app (beta version). The objective of this study is to beta test this app to identify potential bugs and to ensure its usability in a real-world setting.

As part of the expanded beta testing, we will also evaluate the design, functionality, and usability of the JomPrEP app. This step is a critical stage of app development and will increase the ability of our research team to develop an acceptable and effective app.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV-negative MSM
  • Age more than or equal to 18
  • Cis-gender men
  • Condomless sex in the last 30 days
  • Own a smartphone

Exclusion criteria

  • Unable to provide informed consent
  • Unable to read and understand English or Bahasa Malaysia

Treatment and study plan

App usage assessments and analytics

Other

All participants will be given a brief overview of the purpose of the study followed by a survey on participant characteristics and barriers to accessing HIV testing and PrEP uptake and P/SUD support services. The participant will be observed downloading the JomPrEP app and instructed with a brief tutorial on the onboarding process. The participant will be told to keep the app for 1 month and encouraged to use all app components. At 30 days, the participant will complete a post-survey, to which the Systems Usability Scale will be added. App analytics will also be collected (e.g., the number of logins). Participants will be asked to provide feedback on functionality, performance, and errors encountered, motivation to use the app, overall experiences using the app, feedback for further refinement, and subjective impact of the app on HIV prevention.

Primary outcomes

  1. Usability of the JomPrEP app through the System Usability Scale

    Time frame: 1 month

    The Systems Usability Scale (SUS) will be used to assess the subjective usability of the app.

  2. Usability of the JomPrEP app through app analytics

    Time frame: 1 month

    The investigators will collect app analytics, such as the number of log-ins to assess usability.

  3. Usability of the JomPrEP app through app analytics

    Time frame: 1 month

    The investigators will collect app analytics, such as session duration to assess usability.

  4. Usability of the JomPrEP app through app analytics

    Time frame: 1 month

    The investigators will collect app analytics, such as pages visited to assess usability.

  5. Usability of the JomPrEP app through app analytics

    Time frame: 1 month

    The investigators will collect app analytics, such as frequency of use of app components to assess usability.

  6. Usability of the JomPrEP app through app analytics

    Time frame: 1 month

    The investigators will collect app analytics, such as the duration of use of app components to assess usability.

  7. Usability of the JomPrEP app through interviews

    Time frame: 1 month

    Participants will be asked to provide qualitative feedback on functionality, performance, and errors encountered, motivation to use the app, overall experiences using the app, feedback for further refinement, and subjective impact of the app on HIV prevention outcomes.

  8. Acceptability of the JomPrEP app through the System Usability Scale

    Time frame: 1 month

    Point estimates for mean acceptability ≥50 for the System Usability Scale will be considered the minimum criteria for acceptability. The higher the score, the better the outcome. Minimum score for the scale is 0, maximum score is 100.

  9. Acceptability of the JomPrEP app through calculated proportions

    Time frame: 1 month

    Proportion of participants accessing the app >0.60 will be considered the minimum criteria for acceptability.

Secondary outcomes

  1. Feasibility of the JomPrEP app through the System Usability Scale

    Time frame: 1 month

    Point estimates for mean acceptability ≥50 for the System Usability Scale will be considered the minimum criteria for feasibility. The higher the score, the better the outcome. Minimum score for the scale is 0, highest score is 100.

  2. Feasibility of the JomPrEP app through calculated proportions

    Time frame: 1 month

    Proportion accessing the app >0.60 will be considered the minimum criteria for feasibility.

Sponsors and collaborators

Lead sponsor

University of Connecticut

Other

Collaborators

  • University of Malaya
  • Yale University

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Sep 22, 2021
Registry last updated
Sep 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.